Aortech International PLC
20 January 2006
For immediate release 20 January 2006
AorTech International plc
('AorTech' or 'the Company')
Re: Share Price Movement
The Directors of AorTech note the recent movement in the share price of the
Company and know of no reason for today's increase. AorTech confirms that its
strategy to develop commercial products from its Elast-Eon biomaterial is
progressing in line with the expectations of the management.
In December 2005 the Company reported its Interim Results, in which it gave a
full update to the progress of its research and technical discussions with
potential customers. Further updates will be released as soon as is appropriate.
For further information please contact:
AorTech International plc
Frank Maguire, Chief Executive 00 1 801 201 4336
Buchanan Communications 020 7466 5000
Ben Willey, Rebecca Skye Dietrich
Visit AorTech's website at: www.aortech.com
This information is provided by RNS
The company news service from the London Stock Exchange